Additional file 1: of Modest heterologous protection after Plasmodium falciparum sporozoite immunization: a double-blind randomized controlled clinical trial
Jona Walk
Isaie Reuling
Marije Behet
Lisette Meerstein-Kessel
Wouter Graumans
Geert-Jan van Gemert
Rianne Siebelink-Stoter
Marga van de Vegte-Bolmer
Thorsten Janssen
Karina Teelen
Johannes de Wilt
Quirijn de Mast
AndrĂŠ van der Ven
Ernest Diez Benavente
Susana Campino
Taane Clark
Martijn Huynen
Cornelus Hermsen
Else Bijker
Anja Scholzen
Robert Sauerwein
10.6084/m9.figshare.c.3879430_D1.v1
https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_of_Modest_heterologous_protection_after_Plasmodium_falciparum_sporozoite_immunization_a_double-blind_randomized_controlled_clinical_trial/5405755
Protocol. Malaria antigen-specific IgG ELISA (S1). Isolation and cultivation of primary human hepatocytes (S2). In vitro sporozoite infectivity assay of primary human hepatocytes (S3). Immunofluorescent analysis of P. falciparum-infected primary human hepatocytes (S4). In vitro PBMC restimulation with PfRBCs and flow cytometry staining (S5) [11, 12, 14, 17, 42]. (DOCX 20 kb)
2017-09-13 05:00:00
Plasmodium falciparum
Malaria
Vaccine
Sporozoite
Controlled human malaria infection
Heterologous protection
Immune responses